Tango Therapeutics, Inc.·4

Jun 28, 4:29 PM ET

Peters Malte 4

4 · Tango Therapeutics, Inc. · Filed Jun 28, 2022

Insider Transaction Report

Form 4
Period: 2022-06-08
Peters Malte
DirectorPresident & CEO
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-06-08+40,00040,000 total
    Exercise: $5.90Exp: 2032-06-08Common Stock (40,000 underlying)
Footnotes (1)
  • [F1]This option shall vest and become exercisable in 12 substantially equal monthly installments over a period of one year from June 8, 2022, subject to the Reporting Person's continuous service on the board of directors as of each such vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION